<unk>  is a monoamine oxidase (MAO)-B inhibitor (MAOI) that is FDA approved for the {{{indicationType}}} of parkinson’s disease.   Common adverse reactions include flu syndrome, arthralgia, depression, and dyspepsia.
Rasagiline
Selegiline 
Bedaquiline fumarate
Perhexiline
Fendiline
Valpromide
Rimonabant
Deutetrabenazine